and was on azathioprine and prednisone at the time of admission. The patient received adenine arabinoside (Vidarabine) 600 mg intravenously but shortly thereafter developed a high fever, chills, nausea, and vomiting, and the medication was discontinued. At the time of discharge, he complained of double vision," and was found to have a right superior oblique palsy.
At home he became somnolent, increasingly depressed, and had memory lapses. Five Review of literature Fifty-one cases for which there is adequate information are included in our review.4-40 However, several other patients are not included because of the limited information that was provided.4 '42 The mean age of the reported patients with herpes zoster ophthalmicus-contralateral hemiparesis was 58-1 years with a range of seven to 96 years (table). The mean age among the women was 62-5, and among men 54-6. More than 75% of the patients were between the ages of 40 to 75 years. There were 29 men and 22 women. The average interval between the onset of herpes zoster ophthalmicus and that of contralateral hemiparesis was 7-3 weeks, with a range of one week to six months. Thirty patients had herpes zoster ophthalmicus on the left side and 21 on the right. Only 14 patients (28%) had an underlying condition: six were undergoing or recently had undergone chemotherapy for maligancies (lymphosarcoma, prostatic cancer, chronic lymphatic leukaemia (2 patients), breast cancer, and colon cancer); eight had noncancerous conditions (renal failure, rheumatoid arthritis, chronic alcoholism, diabetes mellitus, pancreatitis, myasthenia gravis, and pulmonary sarcoidosis). 
Zoster and contralateral hemiparesis mens from fourteen patients, nine at necropsy, five via temporal artery biopsy or brain biopsy. Necrotising granulomatous angiitis of small and medium meningeal and cerebral arteries were a characteristic finding.92939 Ipsilateral cerebral infarcts were also documented in several patients.5 18 21 36 Temporal artery biopsies were performed in two patients.2230 The first, who had a palpable, tender temporal artery during the onset of contralateral hemiparesis, was found to have lymphocytic and plasmacytic infiltrate of all layers of the vessel, along with minimal intimal proliferation. Temporal artery biopsy in the other patient, however, revealed only arteriosclerosis. In one patient,34 temporal lobe and meningeal biopsies .were performed and were normal. Temporal lobe biopsy in another patient38 revealed meningeal inflammation but no cerebral vasculitis or encephalitis. Occipital lobe biopsy in another patient3" was normal.
Discussion
Various mechanisms for the pathogenesis of herpes zoster ophthalmicus-contralateral hemiparesis have been proposed. Gordon and Tucker" suggested the lesion was vascular in origin with a localised haemorrhage or destructive focus affecting the pyramidal tract. Cope and Jones8 believed that the contralateral hemiparesis was the result of direct invasion by the virus into the pyramidal tract. In 1959, Cravioto and Feigin43 provided the first description of a condition they termed "granulomatous angiitis of the CNS." They described the "proliferation of various mesenchymal cells in the intima, the adventitia, or in all layers of the vessel wall. Giant cells or foreign-body types were prominent." However, Kolodny et al'5 provided the first description of herpes zoster ophthalmicus-contralateral hemiparesis with granulomatous angiitis of the CNS on necropsy. Rosenblum and Hadfield"8 described another patient with herpes zoster ophthalmicuscontralateral hemiparesis and granulomatous angiitis. Both these last patients had disseminated herpes zoster prior to contralateral hemiparesis and a clinical picture of meningoencephalitis.
Linnemann and Alvira" provided the first evidence for viral particles in the outer vessel walls in a patient who had herpes zoster ophthalmicus, disseminated herpes zoster, and meningoencephalitis with granulomatous angiitis at necropsy. They suggested that the granulomatous angiitis of the CNS resulted from direct viral invasion of blood vessels, perhaps by contiguous spread from cranial nerves. MacKenzie et al, 32 proposed that virus spread, probably via vascular branches of the ophthalmic dis-125 tribution of the trigeminal nerve, was the likely pathogenesis. They described the characteristic angiographic findings in this condition.
Doyle et al,36 found viral inclusion bodies in smooth muscle cells of cerebral vessels in a patient who died after herpes zoster ophthalmicuscontralateral hemiparesis. This patient, in contrast with the other patients" 18 did not have disseminated herpes zoster, herpes zoster meningocencephalitis, or predisposing conditions for herpes zoster. The histologic findings were not those of granulomatous angiitis as classically described by Cravioto and Feigin.43 The involvement of the trigeminal ganglion, middle cerebral artery, and tributaries of the middle cerebral, anterior cerebral and basilar arteries, lend support to the proposition of direct viral spread along branches of the ophthalmic division of the trigeminal nerve to the arterial walls.
Clinically, there appears to be a continuum of cases of herpes zoster ophthalmicus-contralateral hemiparesis with "pure" herpes zoster ophthalmicus-contralateral hemiparesis on one end, and herpes zoster ophthalmicus-contralateral hemiparesis with meningoencephalitis on the other. It appears that different clinical variants of herpes zoster ophthalmicus-contralateral hemiparesis represent different degrees of cerebral vascular injury and not distinct, separate entities. Whether the histopathology of these extremes is different remains to be determined.
No proven treatment for herpes zoster ophthalmicus-contralateral hemiparesis has been described. Steroids and anticoagulants have been employed in treating some patients, but the published reports have demonstrated variable results. 12 20253236 Although recent studies with specific anti-herpes drugs have demonstrated efficacy in patients with uncomplicated varicellazoster infections,45-49 the potential benefit of these drugs in treating complications such as encephalitis or granulomatous angiitis is unknown. The apparent efficiency in limiting dissemination and complications with early anti-viral therapy in immunocompromised hosts suggest that these agents need to be tested in all patients with herpes zoster ophthalmicus because of the observed morbidity and mortality.
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